Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.40 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | PTGS1 | P23219 | 4/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 4/20 | 0.38 |
| ▸ | SCD | O00767 | 1/20 | 0.38 |
| ▸ | F13A1 | P00488 | 3/20 | 0.36 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.35 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.35 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.35 |
| ▸ | PTGER3 | P43115 | 1/20 | 0.35 |
| ▸ | PTGER2 | P43116 | 1/20 | 0.35 |
| ▸ | PPARG | P37231 | 4/20 | 0.34 |
| ▸ | PPARD | Q03181 | 4/20 | 0.34 |
| ▸ | PPARA | Q07869 | 4/20 | 0.34 |
| ▸ | HDAC11 | Q96DB2 | 3/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1943663 | 1.00 | TSHR (0.40) | TSHRLMNANFKB1PMP22MEN1 | |
| SCHEMBL18705335 | 0.93 | CYP1A2 (0.35) | TSHRLMNANFKB1PMP22MEN1 | |
| Citric Acid SCHEMBL8916871 | 0.89 | ALDH1A1 (0.40) | TSHRLMNANFKB1PMP22MEN1 | |
| SCHEMBL21986417 | 0.88 | EPHX2 (0.42) | TSHRLMNAHDAC11ALDH1A1 | |
| SCHEMBL29790176 | 0.88 | KMT2A (0.32) | TSHRLMNANFKB1PMP22MEN1 | |
| SCHEMBL1062014 | 0.86 | ALDH1A1 (0.33) | MEN1KMT2AALDH1A1ESR1 | |
| SCHEMBL378264 | 0.83 | SCD (0.38) | TSHRMEN1KMT2ASCDGPR84 | |
| SCHEMBL2159701 | 0.83 | — | — | |
| SCHEMBL8818609 | 0.82 | TSHR (0.39) | TSHRLMNANFKB1PMP22MEN1 | |
| SCHEMBL22070113 | 0.81 | KMT2A (0.38) | KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 839 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3299383-B1 | SPECIFIC MODIFICATION OF ANTIBODY WITH IGG-BINDING PEPTIDE | UNIV KAGOSHIMA (JP) | 2025-12-03 | — | — | EP | claimed |
| EP-3470418-B1 | SITE-SPECIFIC RADIOISOTOPE-LABELED ANTIBODY USING IGG-BINDING PEPTIDE | UNIV KAGOSHIMA (JP) | 2024-07-31 | — | — | EP | claimed |
| US-20240165037-A1 | Colonic Microbiota Responsive Polymer And Its Preparation Method And Use | SHANGHAI JIAOTONG UNIVERSITY SCHOOL OF MEDICINE (CN) | 2024-05-23 | — | — | US | claimed |
| US-20240010712-A1 | ANTIBODIES AGAINST STREPTOCOCCAL M PROTEIN | POLARIS ANTIBODIES AB (SE) | 2024-01-11 | — | — | US | claimed |
| EP-4214230-A1 | ANTIBODIES AGAINST STREPTOCOCCAL M PROTEIN | Tanea Medical AB (SE) | 2023-07-26 | — | — | EP | claimed |
| WO-2022058584-A1 | ANTIBODIES AGAINST STREPTOCOCCAL M PROTEIN | TANEA MEDICAL AB (SE) | 2022-03-24 | — | — | WO | claimed |
| EP-3194964-B1 | MULTIFUNCTIONAL PROTEIN MOLECULAR WEIGHT STANDARDS | LI COR INC (US) | 2021-10-27 | — | — | EP | claimed |
| EP-3544637-B1 | NATIVE OMV-ANTIGEN CONJUGATES AND USE THEREOF | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2020-11-11 | — | — | EP | claimed |
| EP-2776562-B1 | BIODEGRADABLE IMMOBILIZED ENZYMES AND METHODS OF MAKING THE SAME | GUILD ASS INC (US) | 2020-11-04 | — | — | EP | claimed |
| EP-3171171-B1 | RECOMBINANT DEAMIDATED GLIADIN ANTIGEN | BIO RAD LABORATORIES (US) | 2018-07-18 | — | — | EP | claimed |
| EP-0609144-B1 | Immunoassay of an antigen or a hapten | COMMISSARIAT ENERGIE ATOMIQUE (FR) | 1999-05-19 | — | — | EP | claimed |
| WO-1998055864-A2 | SURFACES COATED WITH STREPTAVIDIN/AVIDIN | BIOTEZ BERLIN-BUCH GMBH (DE) | 1998-12-10 | — | — | WO | claimed |
| EP-0407122-B1 | Novel modified PF4 compositions and methods of use | REPLIGEN CORP (US) | 1996-10-02 | — | — | EP | claimed |
| EP-0269092-B1 | METHOD FOR THE DETERMINATION OF A SPECIFIC BINDING SUBSTANCE | Roche Diagnostics GmbH (DE) | 1993-03-10 | — | — | EP | claimed |
| EP-0149654-B1 | DETECTING AGENT CARRYING POLYMER HAVING MULTIPLE UNITS OF VISUALIZATION MONOMER | YALE UNIVERSITY (US) | 1992-09-09 | — | — | EP | claimed |
| EP-0248621-B1 | REAGENT FOR IMMUNOASSAY | KABUSHIKI KAISHA TOSHIBA (JP) | 1992-08-26 | — | — | EP | claimed |
| WO-1989008259-A1 | PROCESS FOR PRODUCING A SOLID PHASE MATRIX | BOEHRINGER MANNHEIM GMBH (DE) | 1989-09-08 | — | — | WO | claimed |
| WO-1988008875-A1 | CYCLING BIOCHIP SENSOR | THE WASHINGTON TECHNOLOGY CENTER (US) | 1988-11-17 | — | — | WO | claimed |
| EP-0269092-A2 | Method for the determination of a specific binding substance | Roche Diagnostics GmbH (DE) | 1988-06-01 | — | — | EP | claimed |
| EP-0184710-A2 | Magnetic microspheres | BAYER AG (DE) | 1986-06-18 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240165037-A1 | Colonic Microbiota Responsive Polymer And Its Preparation Method And Use | SI, PGLS, MGAM | TSHR 4095/4885LMNA 902/4885NFKB1 2114/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.